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The Seventh International Conference on the Genetics of
Streptococci, Lactococci, and Enterococci, sponsored by the
American Society for Microbiology, was held 18 to 21 June
2006, overlooking the sea in Saint Malo, Bretagne, France.
The conference began in 1981 as the Streptococcal Genetics
meeting, at a time when the genera Enterococcus and Lac-
tococcus were still classified as Streptococcus spp. Through
the years, this meeting has served as a quadrennial platform
to showcase cutting-edge advances in the dissection of the
underlying genetics of growth control, metabolism, extra-
chromosomal elements, substrate utilization, competence
development, antibiotic resistance, and virulence of this fas-
cinating group of organisms. The penultimate meeting, held
in 2002, focused heavily on then-recent advances made
through bacterial and phage genome-sequencing projects.
The meeting in Saint Malo highlighted the remarkable
progress over the last 4 years in the areas of functional and
comparative genomics that was spawned by the large-scale
sequencing projects completed early this century. Some of
these advances are summarized in this review of the oral
sessions of the programs, and additional reports published
in this issue of the Journal of Bacteriology provide a more
detailed glimpse of the tremendous insights gained through
genetic analysis of this unique group of eubacteria.
KEYNOTE SESSION
In 1944, the team of Avery, MacLeod, and McCarty re-
ported on the chemical identification of the substance that
induces the transformation of Streptococcus pneumoniae (3).
Their identification of DNA as the hereditary material not only
launched the field of streptococcal genetics, but also provided
a foundation for many of the seminal discoveries in biology and
medicine of the past 62 years. In 2005, the scientific community
lost a member of that team, Maclyn McCarty. Mac brought
both his biochemical expertise and personal drive to bear on
understanding the substance derived from killed bacteria that
led to the fatal bacteremia by otherwise nonvirulent bacteria
injected into Griffith’s mice. Mac spent most of his career as a
physician-scientist at The Rockefeller University and was a
regular attendee of the ASM Streptococcal Genetics meetings.
In the opening presentation in Saint-Malo, Mac’s longtime
colleague and friend, Vince Fischetti, presented a sketch of
Mac’s lifetime of contributions to the understanding of strep-
tococci and the diseases they cause in humans (26). Rheumatic
fever, the often devastating illness that can follow a Strepto-
coccus pyogenes infection, was one challenging puzzle to which
Mac brought important new insights through study of the pa-
tient’s immune response and the biochemistry of the bacteri-
um’s structural features.
The opening session also included talks on comparative
genomics and population genetics. Kira Makarova (working
with Eugene Koonin, National Center for Biotechnology In-
formation) provided highlights of a comparative genomic anal-
ysis of nine species of lactic acid bacteria (LAB). This work
represents one of the most extensive comparative analyses of a
group of closely related prokaryotic genomes. A central theme
in the evolution of LAB is the loss of ancestral genes and
metabolic simplification as a consequence of cellular adapta-
tion to nutritionally rich environments. Past adaptation to nu-
tritionally rich, microaerophilic environments was also evident
in the duplication and acquisition of genes related to sugar
utilization, nitrogen assimilation, and other functions. The
presence of genes encoding putative bacteriocins in most
strains probably reflects long-term adaptation of these cells to
growth and competition in complex microbial communities.
Lactobacillales-specific clusters of orthologous genes (LaCOGs)
from proteins encoded by the sequenced genomes were de-
fined (67). Only 35% of LaCOGs corresponded to the general
COG data set, 22% had no counterpart in the general COG
set, and 11% appeared to be specific to the Lactobacillales
species cluster. Thus, the LaCOGs will be a powerful resource
for genome annotation and evolutionary analysis of the Lacto-
bacillales (47).
The past several years have witnessed the explosive growth
of sequence-based typing schemes for precise identification of
bacterial isolates of a known species. Perhaps foremost among
these tools is multilocus sequence typing (MLST), typically
based on seven neutral housekeeping genes (1). That MLST
can be a lot more than just a tool for cataloguing strains was
made very clear by Brian Spratt (Imperial College, London,
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United Kingdom). Sequence data generated by MLST permits
evaluation of the primary mechanism underlying genetic
change in a bacterial population, namely, recombination versus
mutation (22). MLST can also be used to predict the founders
of medically important clones and their patterns of evolution-
ary descent. This was illustrated for the ST81 clone of S. pneu-
moniae, which has acquired multiple drug resistance genes; has
appeared with several different capsular polysaccharide types;
has undergone changes in housekeeping alleles, mostly by re-
combination; and has traveled the globe in the 30 years
following an unremarkable existence in Spain as serotype
23F-1. Comparison of MLST data from Streptococcus pneumo-
coccus, Streptococcus suis, S. pyogenes, Streptococcus agalactiae,
Streptococcus uberis, and Enterococcus faecalis demonstrated
that there is wide variance among species in the relative impact
of recombination on their evolution. Problems inherent in the
“species concept” (25) were illustrated by the intermingling of
housekeeping gene trees for Streptococcus mitis, Streptococcus
oralis, and S. pneumoniae. MLST has also helped to resolve the
taxonomic confusion surrounding the “atypical” pneumococci,
which are now recognized as Streptococcus pseudopneumoniae.
Bacteria are neither strictly asexual (i.e., clonal) or fully sexual
(e.g., diploid), but rather undergo genetic diversification, in
part by localized recombination. Rooted in the basic principles
of the Fisher-Wright model for sexual organisms, the gap in
population genetic theory for bacteria is beginning to be filled
in with a new multilocus infinite alleles model of bacterial
evolution (24). Recent advances in mathematical modeling
have also led to a simulation of the evolution of a bacterial
population over time, providing a visual display of how se-
quence clusters that drift apart are pulled back together by the
cohesive force of recombination.
POPULATION BIOLOGY AND EVOLUTION
A bacteriophage attack on LAB can spoil a fine French
cheese well before it has ripened and aged via fermentation.
The economic pressures faced by the dairy industry have
helped to advance phage research applicable not only to Lac-
tococcus lactis and Streptococcus thermophilus, but also to hu-
man pathogens, such as S. pyogenes and Streptococcus mutans.
As outlined by Louis-Charles Fortier (University Laval), there
are a large number of genetically diverse groups of lactococcal
phage (21). Comparative genomics studies have uncovered
several interesting parallels between L. lactis and S. pyogenes
phage and between S. thermophilus and S. mutans phage. Bac-
teriophage control has important implications, not only for the
dairy industry, but also for novel therapies against bacterial
infections of mammalian hosts (23).
Genetic steps that allow a bacterium to exploit a new eco-
logical niche were delineated in the presentation by Rob Wil-
lems (University Medical Center Utrecht). The highly success-
ful clonal complex (CC17) of hospital-adapted Enterococcus
faecium has become the vancomycin-susceptible precursor for
many vancomycin-resistant enterococci. Interestingly, the eco-
logical abundance of CC17 is much higher in the hospital than
in farm animals, where the use of glycopeptide antibiotics in
feed has been controversial. Hospital adaptation by CC17—a
highly specialized enterococcal genetic subpopulation—ap-
pears to be a multistep process in which genes acquired by
horizontal transfer provide a selective advantage in exploiting
the hospital environment. This leads to an increase in clonal
frequency that facilitates further adaptive possibilities (72).
Genes encoding resistance to other antibiotics (ampicillin and
ciprofloxacin) and virulence factors (the esp-associated patho-
genicity island) were acquired by CC17 organisms in their
adaptation to the hospital. Comparative genomic hybridization
using microarrays has identified 100 candidate genes, some
of which may have roles in increasing the fitness of CC17 in the
hospital environment. Through better understanding the CC17
precursors of vancomycin-resistant enterococci, it may be pos-
sible to devise strategies that minimize the emergence of un-
treatable nosocomial infections.
The pneumococcal conjugate vaccine (PCV7) consists of
seven capsular polysaccharides covalently linked to diphtheria
toxoid. A few years prior to its licensing in 2000, a mathemat-
ical model predicted that organisms of the serotypes included
in PCV7 would likely be replaced by organisms of other sero-
types (41). Bernie Beall (Centers for Disease Control and
Prevention) reported that PCV7 has already been a huge suc-
cess in its target age group (children) and has also led to a
reduction in adult disease via a herd effect. However, serotype
19A, a capsular type not included in PCV7, has recently
emerged as the most prevalent serotype associated with pneu-
mococcal invasive disease in the United States. This new vir-
ulent clone appears to have arisen following horizontal transfer
of a 39-kb DNA fragment containing serotype 19A capsule and
PBP1a genes from an ST199 donor strain to a serotype
4-ST695 recipient strain. Serotype 4 capsular polysaccharide
corresponds to one of the seven vaccine serotypes successfully
targeted by PCV7. This single genetic replacement event ap-
pears to account for the emergence of this highly virulent
vaccine escape mutant on the ST695 background.
As the number of complete genome sequences increases,
comparative genomic analysis becomes more powerful. Mat-
thew Holden (The Wellcome Trust Sanger Institute, Cam-
bridge, MA) compared the genome sequences of representa-
tive isolates of four streptococcal pathogen species (S.
pyogenes, S. uberis, S. suis, and Streptococcus equi) that primar-
ily infect four different host species (human, bovine, porcine,
and equine, respectively). Species comparisons of orthologues
revealed core and accessory genes that are species specific,
thereby providing new insights into specific niche adaptations
and pathogenic processes. Mobile genetic elements contribute
to the accessory gene makeup. The proportion of the genome
comprised of mobile genetic elements was found to be higher
for S. pyogenes and S. equi than for S. suis and S. uberis.
GENE TRANSFER, COMPETENCE,
AND RECOMBINATION
Don Morrison (University of Illinois at Chicago, Chicago,
IL) provided an overview of the biology of competence in the
pneumococcus. This transient phenomenon develops suddenly
as a consequence of the accumulation of a peptide pheromone,
CSP, which participates in cell-cell signaling through a posi-
tive-feedback loop and a transcriptional cascade involving a
two-component signal transduction system (ComDE) and an
alternative sigma factor (ComX). Transcription of 100 genes
in 30 operons is briefly induced (16, 53). While the wide-
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spread display of competence in this species implies a strong
selective pressure for its maintenance, the observation that
70% of the induced genes are not required for DNA uptake
and processing suggests that competence does not develop
only for the purpose of genetic transformation. Recent reports
revealing that competence is also associated with a transient
propensity to cause lysis of noncompetent neighbors (referred
to as allolysis or fratricide) are consistent with this view. Six of
the CSP-induced genes are now known to participate either in
allolysis (lytA and cbpD, which encode amidases, and cibA-
cibB, which encode a two-peptide bacteriocin) or in establish-
ing immunity against lytic factors in competent cells (comM
and cibC) (28, 30, 33). This remarkable form of cooperative
aggression might serve to sample the genomes of nearby bac-
teria. However, allolysis of a subpopulation may also contrib-
ute to interactions with the host in ways unrelated to gene
transfer. It could provide, for example, a mechanism for the
regulated release of the intracellular virulence factor pneumo-
lysin. At least 13 of the operons induced by CPS are devoid of
genes implicated in the regulation of competence, DNA up-
take, genetic recombination, lytic interactions, or immunity.
Additional unknown but similarly coordinated activities may
remain to be discovered. Some could account for the recent
observation that administration of CSP can grossly alter the
outcome of experimental sepsis.
Coregulation of bacteriocin production and competence is
also known to occur in S. mutans. Fengxia Qi (University of
California at Los Angeles) reported recent investigations of
the underlying regulatory mechanism. Bacteriocin (mutacin
IV) production and competence development were previously
shown to be coordinated through transcription regulation by a
three-component quorum-sensing system called comCDE. The
comC-encoded CSP has now been found to regulate a group of
bacteriocin-like genes, in addition to mutacin IV production.
Interestingly, the bacteriocin-encoding genes respond immedi-
ately to CSP, whereas the response of the comC gene is de-
layed for 1.5 to 2 h after CSP addition (37). Moreover, expres-
sion of the bacteriocin genes absolutely requires the presence
of comE, while deletion of comE enhanced comC gene expres-
sion to the same level as addition of CSP. Point mutations
mimicking the phosphorylated and nonphosphorylated forms
of ComE were used to demonstrate that transcriptional acti-
vation of the bacteriocin genes requires the CSP-induced
ComDE phosphorylation cascade (and binding of ComEP to
direct repeats identified in front of the CSP-induced genes)
and that the same system induces competence gene expression
indirectly through relief of ComE-dependent repression of
comC. These findings, which are in contrast to the S. pneu-
moniae paradigm, are fully consistent with recent observations
showing that S. mutans ComDE is not the orthologue of S.
pneumoniae ComDE but of BlpRH (42), a two-component
system controlling expression of bacteriocin-like genes. The
regulatory link between S. mutans ComCDE and the compe-
tence-specific sigma factor ComX remains to be understood.
Conjugative transposons are believed to play important roles
in the shaping and the evolution of variable genomic islands in
bacterial chromosomes. Ge´rard Gue´don (Universite´ Henri
Poincare´, Nancy, France) provided support for the view that
several genomic islands of S. thermophilus are integrative and
conjugative elements (ICEs) or ICE-derived elements (52)
evolved by deletion and tandem accretion resulting from site-
specific recombination. Excision of ICEs involves tyrosine-in-
tegrase-mediated recombination between two 27-bp direct re-
peats included in the two attachment sites of ICEs, attL and
attR. cis-mobilizable elements would presumably arise from
ICEs by deletion of the conjugation and recombination mod-
ules, whereas integration of an ICE acquired by conjugation by
site-specific recombination between attI of its circular form and
an att site flanking a resident cis-mobilizable element or ICE
would lead to evolution of a preexisting genomic island.
Philippe Glaser (Institut Pasteur, Paris, France) described
the characterization of a novel class of conjugative transposons
identified in highly variable islands of the S. agalactiae genome,
as well as in group B streptococcus (GBS) strains and in Strep-
tococcus gallolyticus. These transposons harbor 23-bp inverted
repeats at their extremities and generate 9-bp duplications
upon integration. In contrast to all gram-positive conjugative
transposons described so far, which require the action of site-
specific serine or tyrosine recombinases, each of the putative
transposons potentially encodes a transposase containing the
DDE motif. PCR-based detection of the circular forms of
these elements suggested that the transposases are active. In
addition, one of these putative transposons (Tngbs2) was
shown to be transmissible among S. agalactiae strains by filter
mating, consistent with the presence of open reading frames
encoding proteins similar to the conjugation proteins TraG
and TraE of the E. faecalis conjugative plasmid pCF10. Alto-
gether, these observations support the view that these elements
constitute a new class of conjugative transposons involved in
the evolution of group B streptococci.
Sergey Artiushin (University of Kentucky) reported an anal-
ysis undertaken to understand the features unique to S. equi
that account for its enhanced virulence and narrow adaptation
to equids compared with Streptococcus zooepidemicus. The lat-
ter is an opportunistic pathogen of the respiratory and repro-
ductive tracts that lacks host specificity and is antigenically
highly variable. The use of subtractive libraries made by using
S. equi as a tester and S. zooepidemicus as a driver DNA led to
the identification of mobile-element sequences accumulated in
the genome of S. equi. Inactivations of a number of potentially
important genes through mobile-element expansion and phage
acquisition were proposed to represent important events in the
formation of the clonal, highly host-adapted S. equi from an
ancestral S. zooepidemicus.
The resolution of circular chromosome dimers accidentally
produced in bacteria is essential for correct chromosome trans-
mission to daughter cells. In the paradigmatic Escherichia coli,
chromosome dimer resolution is achieved through site-specific
recombination at the dif site, a 28-bp sequence located near the
terminus of chromosome replication. Two tyrosine recombi-
nases, XerC and XerD, catalyze a concerted strand exchange
reaction. This reaction is intimately coupled with cell division
by the septal DNA translocase FtsK, which brings together the
two dif sites of a dimer at the division septum and activates
cleavage through direct interaction with XerD. Pascal Le Bour-
geois (and Paul Ritzenthaler; LMGM CNRS-Universite´ Paul
Sabtier, Toulouse, France) reported that in contrast to this para-
digm, streptococci and lactococci, but not enterococci, use an
exotic 31-bp recombination site, difSL, and only one tyrosine-
recombinase, XerS, encoded by a gene adjacent to difSL.
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SENSING AND SIGNALING
Two-component signal transduction systems are likely to
play a key role in the adaptation to different environments
within the human host by many streptococcal species that are
otherwise devoid of stationary-phase or stress-responsive sec-
ondary sigma factors. June R. Scott (Emory University) de-
scribed recent findings concerning the role of the CovRS sys-
tem of S. pyogenes. This regulation system has been shown by
microarray analysis to regulate 15% of the M1 group A
streptococcus (GAS) genome, including genes encoding sev-
eral virulence factors. Unlike most response regulators that
activate gene expression, CovR functions chiefly as a repressor
of transcription. Inactivation of CovR by its cognate sensor
kinase, CovS, is required for the growth of GAS under stress
conditions (18). Inactivation of covS prevents growth under
mild stress conditions (pH 6, 40°C, or high salt), suggesting
that CovR controls genes important for stress responses. One
such operon, rscAB, encodes a homologue of the ABC ex-
porter MDR1 (17). It is speculated that this operon is required
for the export of products that are toxic under stress conditions
or that it affects the movement of specific membrane lipids,
thus allowing appropriate membrane composition and fluidity
for growth at high temperatures.
In contrast to most quorum-sensing systems that involve a
single cell type whose population density in a particular niche
is sensed by using a signal molecule, the pheromone system
regulating conjugative transfer of the antibiotic resistance plas-
mid pCF10 in E. faecalis involves two distinct populations,
donor cells and plasmid-free recipients. Gary Dunny (Univer-
sity of Minnesota) reviewed the most recent data on the mo-
lecular mechanisms regulating the induction of a pCF10-con-
taining cell in response to the mating pheromone cCF10
produced by plasmid-free recipient cells. This induction is con-
trolled by a complex sensing system involving multiple sets of
positively and negatively acting regulatory molecules. They
include two plasmid-encoded factors (iCF10 and PrgY) and
active and inactive forms of the cytoplasmic pheromone recep-
tor PrgX. Recent structural analysis of complexes between
PrgX and cCF10 or iCF10 have revealed that both peptides
interact with the same peptide-binding pocket of PrgX but
induce different conformational alterations in the protein, re-
sulting in opposite effects on its oligomerization state (61).
Another key parameter, the balance of iCF10 and cCF10 in the
growth medium, depends on the level of expression of the prgQ
locus encoding iCF10 production, as well as on the control of
endogenous pheromone production by PrgY. In addition, hu-
man plasma induces pCF10 transfer and expression of the
aggregation substance Asc10 by causing endogenous phero-
mone induction, probably by disrupting the iCF10/cCF10 ratio
(14). Altogether, the data indicate that this complex control
system serves multiple functions in that it allows the cell to
detect the presence of recipient cells in close proximity and to
ascertain that its growth environment is the mammalian blood-
stream. The pheromone-inducible aggregation substance
Asc10 increases virulence in several animal models, consistent
with the view that the sensing system has evolved to control not
only conjugation functions, but also virulence.
The production of bacteriocins by LAB is of great interest
because of their potential use as natural preservatives in food
products. Laetitia Fontaine (and Pascal Hols; Universite´
Catholique de Louvain, Louvain, Belgium) reported the study
of a class II bacteriocin locus identified in the genome of S.
thermophilus (9) on the basis of homology to the previously
characterized blp locus of S. pneumoniae (20). These loci con-
tain genes encoding a typical quorum-sensing regulatory mod-
ule composed of a conserved two-component system, BlpRH;
the corresponding inducer pheromone, BlpC; and its dedicated
proteolytic ABC transporter, BlpAB. A variable number of
genes encoding bacteriocin-like peptides containing a typical
double-Gly leader are located downstream of blpRH in three S.
thermophilus strains (31). The addition of synthetic BlpC to
one of these strains was shown to induce transcription of the
bacteriocin-encoding genes and the production of bacteriocins
active against S. thermophilus, as well as other species. Modu-
lation of the inhibitory spectrum of S. thermophilus could be
demonstrated through the combination of different blp-en-
coded bacteriocins.
Defining the regulon under the control of a two-component
regulatory system is not an easy task. It proved to be even more
complicated in the case of CiaRH of S. pneumoniae, which has
been implicated in -lactam resistance, protection from a va-
riety of lysis-inducing conditions, competence, and virulence.
Transcriptome analyses (16, 43, 59) and genomewide solid-
phase DNA binding assays with the response regulator CiaR
(43) resulted in inconsistencies in the definition of the CiaR
regulon and revealed no obvious link to most of the observed
phenotypes. Reinhold Bru¨ckner (and Regine Hakenbeck; Uni-
versity of Kaiserslautern, Kaiserslautern, Germany) presented
new data that may open the way to a better understanding of
CiaR-mediated regulation. Briefly, a CiaR-binding sequence
was first identified by gel shift analysis and mutagenesis. The
genome sequence of S. pneumoniae R6 was then searched
using this sequence, leading to the detection of several new
putative CiaR-regulated promoters. Intriguingly, the five
strongest CiaR-regulated promoters were found to be located
upstream of genes that were apparently not regulated by
CiaRH but expressed from CiaR-independent promoters lo-
cated closer to the respective genes than the CiaR-controlled
promoters. Inspection of the DNA sequences immediately
downstream of these CiaR-dependent promoters revealed the
capacity to code for 100-nucleotide-long RNAs with a high
degree of similarity to each other. Characterization of these
RNAs will undoubtedly clarify the regulatory link to CiaRH-
dependent phenotypes.
The regulation of nitrogen metabolism is of paramount im-
portance for the survival of bacteria in a variety of different
environments. Oscar Kuipers (University of Groningen, Gro-
ningen, The Netherlands) described the results of detailed
comparative studies of the regulatory roles of GlnR and CodY
in L. lactis and S. pneumoniae, combining the use of microar-
rays, lacZ-reporter fusions, in vitro analysis of protein-DNA
interactions, and mouse infection. A conserved CodY box
identified in L. lactis could also be found in relevant promoters
in S. pneumoniae (19). A similarly identified GlnR box was also
found to be conserved in both species (36, 38). Dual regulation
by both CodY and GlnR of a few genes differing between L.
lactis and S. pneumoniae pinpointed presumably important
control points of the cellular nitrogen status of each species.
Mouse infection studies and in vitro assays of adhesion to
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human nasopharyngeal cells provided evidence that both
CodY and GlnR regulons have a significant impact on the
virulence of S. pneumoniae.
CELL SURFACE BIOGENESIS AND FUNCTION
The fourth oral session at the conference was dedicated to
current advances in the understanding of protein secretion and
the biogenesis and functions of cell surface proteins of patho-
genic streptococci. Jeannine Brady from the University of Flor-
ida expanded on her recently published work (29) that detailed
fundamental differences in the requirements for the protein
secretion machinery of Streptococcus mutans. Specifically, de-
letion of critical components of the signal recognition particle
cotranslational protein secretion pathway (Ffh and FtsY) that
were believed to be required for viability of all forms of life
revealed that these components are dispensable in S. mutans.
The molecular basis for this was disclosed by demonstrating
that S. mutans carries two copies of genes encoding homo-
logues of the YidC/OxaA/Alb3 family of membrane proteins
mediating protein translocation in prokaryotes, mitochondria,
and chloroplasts, respectively. Inactivation of yidC2 and ffh in
a single strain was not possible, demonstrating that YidC2 can
compensate for the lack of an intact signal recognition particle,
and vice versa. It was also notable that the duplication of yidC
genes occurs in the genomes of related streptococci for which
complete sequence information is available. Thus, fundamen-
tal differences are evident in the ways in which this unique
group of organisms moves proteins to the cell surface and
beyond.
“Streptococcologists” have led the way in the discovery and
dissection of surface-localized, glycosylated proteins in bacte-
ria. Paul Sullam (University of California at San Francisco)
provided a detailed update on progress on the interrelation-
ship of secretion and glycosylation of the GspB surface glyco-
protein of Streptococcus gordonii. GspB is encoded in a locus
containing genes required for transport and glycosylation and
has served as the paradigm for proteins in related streptococci
and staphylococci (7). GspB is secreted through an accessory
Sec system encoded in the gspB gene cluster, and glycosylation
is critical for the stability of the adhesin (5, 65, 66). Still, GspB
can also exit the cell through the canonical Sec system. How-
ever, glycosylation of GspB prevented efficient export through
the canonical system, implying that the accessory Sec system
has evolved specifically for export of glycosylated proteins in a
posttranslational secretion pathway. Experimental evidence
was presented to show that GspB appears to be targeted to
this specialized accessory secretion pathway by an atypical 90-
amino-acid signal sequence (8).
Hui Wu (University of Alabama at Birmingham) continued
the excursion through the genetics and function of glycosylated
streptococcal surface proteins and of accessory proteins in-
volved in their modification and transport. The Fap1 adhesin
of Streptococcus parasanguis, which appears to have been ac-
quired by horizontal gene transfer (64), is a 2,570-amino-acid
fimbria-associated protein that is heavily decorated with car-
bohydrate through O linkages. Two genes, gtf and secY2, the
latter encoding an accessory Sec system similar to that de-
scribed above, are differentially involved in Fap1 glycosylation
(15). Loss of SecY2 led to elimination of one type of glycosyl
moiety from the mature Fap1 protein, but the partially glyco-
sylated precursor was still exported to the cell surface. In con-
trast, mutants lacking the gtf gene produced a nonglycosylated
Fap1 precursor. Notably, biofilms formed by the gtf and secY2
mutants exhibited markedly different architectures, clearly
demonstrating the importance of posttranslational modifica-
tion and proper secretion and localization of Fap1 for the
pathogenic potential of S. parasanguis.
Caparon and coworkers first described what is an apparent
specialized protein translocation apparatus located in foci in
Streptococcus pyogenes, known as the ExPortal (57). Among
the proteins identified as colocalizing at the ExPortal is sortase,
an enzyme that catalyzes the covalent linkage of cell surface
proteins to peptidoglycan through the threonine residue in
conserved LPXTG sequences found in a subset of secreted
proteins of streptococci and related organisms (48). Kimberly
Kline from Washington University in Saint Louis, MO, de-
scribed attenuation of virulence in a mouse urinary tract in-
fection model resulting from inactivation of sortase of Entero-
coccus faecalis. To determine whether sortase could be
localized to the ExPortal, immunolocalization studies were
performed to demonstrate that sortase and SecA colocalized at
a punctate site on the cells characteristic of the ExPortal. It was
also noted that proteins that are known to localize at the
ExPortal carry an unusually large number of positively charged
residues in juxtaposition to a C-terminal transmembrane do-
main. Mutation of these residues in sortase affected ExPortal
localization, and a significant number of proteins carrying this
signature, termed the ExPortal targeting sequence, could be
identified in the genome. Preliminary information showing that
there was a preponderance of anionic lipid localized at the
ExPortal suggested that perhaps the positively charged ExPortal
targeting sequence facilitates the interaction with the export site,
consistent with a recent report on localized protein secretion in
group A streptococci (13).
The final presentation of this oral session was given by
Katrin Dinkla from the German Research Center for Bio-
technology and highlighted critical structure-function rela-
tionships in the fibronectin binding proteins of group A and
G streptococci (35, 69). S. pyogenes produces streptococcal
fibronectin binding protein I (SfbI), which triggers adher-
ence and the invasion of epithelial cells (45). An apparent
homologue of SfbI, GfbA, was identified in group G strep-
tococci and was shown to enhance adherence to skin fibro-
blasts. A knockout mutant lacking GfbA and heterologous
expression of gfbA in the noninvasive host Streptococcus
gordonii supported the notion that GfbA contributes signif-
icantly to the ability of cells to invade human epithelial cells.
Importantly, S. gordonii expressing sfbI was targeted to
caveosomes, whereas GfbA-producing recombinant S. gor-
donii localized in lysosomes. GfbA and SfbI are 97 to 100%
identical in the fibronectin binding domains and the proline
repeat regions but differ significantly (60% homology) in the
aromatic-rich domains, suggesting that the differences in
subcellular targeting observed between the parental organ-
isms and recombinant S. gordonii strains may be attributable
to differences in the aromatic domains of these two surface
proteins.
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PATHOGENESIS
Serine/threonine kinases, which are widely used in the eu-
karyotic world to modulate gene expression, have recently
been detected in a variety of prokaryotes. A single serine/
threonine kinase, Stk1, was identified by Lakshmi Rajagopal
and coinvestigators in Craig Rubens’ laboratory at the Univer-
sity of Washington in Seattle (54). An apparent serine/threo-
nine phosphatase (Stp1) was also identified in the same strain.
Stk1 mutants showed a substantial decrease in virulence and
survival in blood and displayed enhanced susceptibility to
phagocytosis. Notably, Stk1 regulates the expression of cylE,
encoding the -hemolysin of the organism, but this regulation
appears to be exerted through CovR of the CovRS two-com-
ponent system. CovR has been shown to regulate 138 genes in
GBS, so a role for Stk1 in global regulation of virulence ap-
pears likely.
Genomics and microarrays have revolutionized the study of
pathogenic streptococci and have allowed the identification,
for example, in the case of Stk1 in GBS, of central regulatory
elements globally regulating virulence gene expression. Paul
Sumby from Jim Musser’s group in the Methodist Hospital in
Houston, TX, detailed their work on ex vivo and in vivo models
for transcriptome profiling of GAS. Growth of GAS in blood
or saliva resulted in major remodeling of the transcriptome of
the organisms. Over 500 genes were differentially expressed in
blood, including the streptolysin S operon and pilus proteins,
with an overall remodeling to adapt to this new microenviron-
ment. Growth in saliva also resulted in dramatic changes in
gene expression (60), including a 2,300-fold increase in speB,
encoding a cysteine proteinase. Longitudinal analysis of the
transcriptome in primates revealed distinct responses of the
organisms to environments encountered during colonization,
during the acute phases of the disease, and beyond (70). Per-
haps not surprisingly, two-component systems appear to be
heavily involved in these responses in vivo, and evidence was
also presented that prophage may be induced in vivo during
infection.
Tim Mitchell of the University of Glasgow gave an excellent
overview of the pathogenesis of pneumococcal diseases. A
major focus of the presentation was to highlight the tremen-
dous genetic heterogeneity and plasticity of pneumococci. For
example, PspC of the pneumococcus is a surface protein that
contributes to complement and phagocytosis resistance
through binding of factor H and the C3 component of com-
plement. In addition, this protein contributes to adherence and
invasion through binding of immunoglobulin receptor (34).
However, inactivation of pspC in four different strains of pneu-
mococci had dramatically different effects on pathogenesis.
Interestingly, a population-based study using comparative ge-
nome hybridization and multilocus sequence typing showed
that there are three new regions of high genetic diversity in
identical MLST types and capsular serotypes. Importantly,
these strains behave dramatically differently in animal models.
Building on the concept of bacterial adaptation to host mi-
croenvironments, Claire Poyart presented highly significant
findings about oxygen, aerobic metabolism, and virulence of
GBS. Notably, GBS, which like other streptococci are gener-
ally considered to rely exclusively on fermentation for ATP
generation, were shown to be able to assimilate heme and
menaquinone from blood to activate a respiratory chain, dou-
bling the growth yield compared with fermentation alone (73).
Mutations in cydA, encoding a subunit of cytochrome bd quinol
oxidase, resulted in exclusively fermentative growth but also
attenuated virulence in a neonatal-rat sepsis model. Attention
then turned to the H2O-forming NADH oxidase Nox-2. When
the nox2 gene was inactivated, growth of the organisms in
elevated oxygen concentrations was affected and the organisms
acquired sensitivity to paraquat and peroxide. Interestingly,
glucose utilization and lactate production were not affected in
the nox2 mutant strain, but acetate was not produced. Also,
good growth in the presence of oxygen by the mutant could be
restored by the addition of exogenous acetate, which was
shown to be, at least in part, attributable to provision of ade-
quate levels of acetyl-coenzyme A to support fatty acid biosyn-
thesis. Addition of menaquinone and heme could also bypass
the nox2 defect, and nox2 mutant strains showed decreased
virulence and lower numbers of organisms in the blood and
brains of infected animals.
Jennifer Mitchell presented the final talk in this session,
detailing a novel method for biogenesis of platelet binding
proteins on the surface of Streptococcus mitis, an oral strepto-
coccus that is a significant contributor to bacterial endocarditis.
Two surface proteins, PblA and PblB, are required for platelet
binding and are encoded on the lysogenic bacteriophage SM1
(6). Neither of the proteins is translated with a classical signal
sequence, nor do they contain LPXTG anchor sequences. In-
duction of the phage by mitomycin C or UV light enhanced the
levels of surface-localized PblAB. Inactivation of the holin-
lysin genes of phage SM11 demonstrated that these proteins
were required for release of PblAB from the cells and de-
creased platelet binding activity. Pure PblA and PblB added to
mutant cultures became associated with the surface of S. mitis,
possibly through GW-rich (glycine-tryptophan) sequences im-
plicated in choline binding. Thus, populations of S. mitis can
enhance their platelet binding potential by prophage induction
to release PblA and PblB, a form of “bacterial altruism” that
may be used in vivo to modify the adhesive repertoire of the
organisms under conditions that trigger phage induction. The
presence of these virulence genes on a phage could allow
dissemination to related organisms.
PATHOGENESIS AND GENETICS
S. pyogenes is a highly prevalent pathogen that usually causes
only a mild disease in its human host. However, there are an
unlucky few who develop toxic shock syndrome. According to
Malak Kotb (University of Tennessee at Memphis), the rea-
sons why this is so are multifactorial and depend on the infect-
ing strain, the genetic background of the host, and the unique
host-pathogen interaction that ensues. The M1T1 strain has
been predominant in toxic shock syndrome cases for more than
25 years, and its associated phage are highly mosaic in struc-
ture, harboring an array of toxin genes (4). Several of the toxin
genes encode superantigens that interact with HLA class II
antigens, whereby different HLA types can confer risk or pro-
tection from severe invasive streptococcal disease. A mouse
sepsis model was used to identify susceptible and resistant mice
generated by F2 crosses over many generations, leading to
quantitative trait loci that can be mapped. Invasive-disease
1214 MEETING REVIEW J. BACTERIOL.
 o
n
 April 21, 2016 by UTAH STATE UNIV
http://jb.asm.org/
D
ow
nloaded from
 
severity is also influenced by the amount of SpeB cysteine
protease that is produced by the infecting strain, and high
levels of SpeB production are associated with less severe dis-
ease because other streptococcal virulence factors are de-
graded.
The structure and function of the pathogenicity island (PAI)
of E. faecalis were detailed by Janet Manson (Schepens Eye
Research Institute). This 153-kb PAI has many of the expected
features, such as altered GC content and ends having ho-
mologies to other mobile genetic elements. It also has genes
for some well-characterized virulence determinants, including
aggregation substance, cytolysin, and Esp, which enhances col-
onization in the urinary tract. A bile salt hydrolyase gene was
examined as a novel virulence trait. The bile salt hydrolase was
found to reduce bile toxicity by cleavage of a side group that
otherwise enhances bile salt solubility in the low-pH environ-
ment of the gastrointestinal tract. Stress response genes also
appear to be components of this PAI.
Why does S. pyogenes grow in chains? This is a seemingly
simple question with an elusive answer. One possibility lies in
the sacrifices that are made when phage lysogenize, producing
host toxins that enhance the survival of the remaining intact
bacterial cells. In searching for proteins secreted by S. pyogenes
during contact with a pharyngeal cell line, the laboratory of
Vince Fischetti (The Rockefeller University) uncovered two
phage products, a toxin (SpeC) and a DNase (Spd1) (11).
Unlike many other toxinogenic phage, the induction of lyso-
genic phage in streptococcal-epithelial cell coculture demon-
strates the lack of a requirement for damage to the bacterial
chromosomal DNA. The phage-inducing factor is diffusible but
has not yet been identified. New phage infection was shown to
occur with high efficiency using marked donor and recipient
bacterial strains following their colonization of the oropharyn-
geal cavity of the mouse. Perhaps the role of DNase is to free
the phage particle after bacterial-cell lysis. For the S. pyogenes
bacteriophage, the mammalian host appears to be an essential
component of its life cycle.
ADAPTATION AND LIFESTYLE
Like many eubacteria, streptococci and related microorgan-
isms display remarkable adaptive flexibility to different envi-
ronmental challenges or lifestyle changes. Since each of these
cellular functions is scripted by the dynamic and coordinated
expression of various gene regulons, detailed knowledge of
gene content and global gene regulation in streptococci, lac-
tococci, and enterococci continues to generate astounding new
insights into the biology of these important microbes. Pierre
Renault (INRA, Jouy en Josas, France) described key similar-
ities and differences between lactococcal and S. mutans regu-
lons for nitrogen assimilation and amino acid biosynthesis. The
pleiotropic transcriptional repressor CodY, for example, is
highly conserved in many low-GC gram-positive species (55).
Transcriptome analysis of L. lactis has shown that CodY is
involved in global control of nitrogen metabolism and re-
presses over 100 genes in response to the intracellular accu-
mulation of branched-chain amino acids, particularly isoleu-
cine (27). Pathways subject to CodY regulation in lactococci
included those associated with protein degradation, peptide
and amino acid uptake, and de novo amino acid biosynthesis.
Genome scans have identified the CodY-binding site, first de-
fined in L. lactis via a combination of bioinformatics and ge-
netics experiments, in the promoter region of nitrogen-related
genes in streptococci and other gram-positive bacteria. How-
ever, putative CodY targets in lactococci and streptococci also
show interesting differences that suggest this repressor may
control other cellular processes, such as cell communication or
host interaction, in one genus but not the other. Renault de-
scribed additional differences between lactococci and S. mu-
tans in metabolic regulation of sulfur-containing amino acids.
Control of methionine metabolism in gram-positive bacteria,
for example, is typically effected by S-box or T-box mecha-
nisms, whose actions are exerted at the level of premature
transcriptional termination. However, Rodionov et al. (56)
found that streptococci, lactococci, and enterococci lacked S
boxes, as well as methionine-specific T boxes, but noted that
streptococci did contain a palindromic motif, termed the MET
box, in the upstream sequence for most Met-related genes.
Only one copy of the MET box was located in L. lactis, how-
ever, and Renault and coworkers determined that lactococci
utilize a single transcriptional activator, FhuR, to regulate
most genes involved in sulfur amino acid biosynthesis and that
the FhuR consensus binding site is different from the MET
box (62).
An even more pronounced paradigm difference was de-
scribed by Jose Lemos (and Robert Burne; University of Flor-
ida), who reported on the mechanism by which S. mutans and
related species control intracellular levels of (p)ppGpp alar-
mone. This alarmone acts as a global regulator for microbial
adaptation to numerous adverse environmental conditions, in-
cluding some that result from biofilms or host colonization. In
gram-negative cells, synthesis and hydrolysis of (p)ppGpp is
catalyzed by two proteins, RelA and SpoT. RelA acts as a
synthetase, while SpoT is a bifunctional enzyme with syn-
thetase and hydrolase activities (32). In streptococci and other
gram-positive bacteria, however, (p)ppGpp synthetase and hy-
drolase activities are both provided by a bifunctional RelA
enzyme (44). Curiously, S. mutans relA null mutants were
found to still be able to produce (p)ppGpp but were defective
in biofilm formation (40). Here, Lemos described genes for
two novel relA-like proteins (termed RelP and RelQ) that were
identified in the S. mutans genome. One of these genes, relP, is
under the control of a cotranscribed two-component regula-
tory system. Mutation analysis showed that inactivation of relP
and its cognate two-component regulatory system abolished
(p)ppGpp production in S. mutans, while relQ inactivation
produced cells whose phenotype was similar to that of the relA
mutant. Protein homology searches identified RelP and RelQ
paralogs in other low-GC species of bacteria, suggesting
more widespread deviation from the current dogma that RelA
is the only enzyme for (p)ppGpp synthesis in bacteria.
Stress adaptation and other cellular processes associated
with the transition by streptococci between planktonic and
more environmentally resistant sessile (biofilm) lifestyles con-
tinues to attract considerable research interest. The structur-
ally complex nature of biofilms provides greater protection
against environmental extremes and antimicrobial agents and
makes them difficult to control as sources of contamination or
disease. The transition to sessile life is an organized process
that starts with a cell density-dependent process called quorum
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sensing (2), and one of the best-understood mechanisms for
quorum sensing in streptococci involves the induction of ge-
netic competence. Marco Oggioni (University of Siena, Siena,
Italy) and coworkers analyzed S. pneumoniae transcription
during blood and tissue infections in mice and found that the
gene expression profile for cells in blood was very similar to
that of laboratory-grown planktonic cells. In contrast, cells
recovered from tissue infections showed an expression profile
that was more akin to that seen in a biofilm model. Interest-
ingly, biofilm induction in the model required the quorum-
sensing competence-stimulating peptide CSP, and CSP also
increased cell virulence in the pneumonia tissue infection
model but reduced virulence in the sepsis model. Challenge
studies with a comD mutant (deficient in CSP signaling)
showed the opposite response in tissue and sepsis models, and
these observations were further confirmed in experiments us-
ing laboratory-grown cells from biofilm or planktonic culture
(51). Based on these findings, Oggioni postulated that viru-
lence in pneumococci is directly related to lifestyle, where
sepsis infections are favored by a planktonic state and tissue
infections by a biofilm-like state.
The implication of CSP activity in biofilm formation is con-
sistent with the knowledge that this peptide must be involved in
processes other than natural genetic transformation, since only
23 of the more than 120 genes it induces in S. pneumoniae are
needed for genetic competence. Another process that has been
linked to CSP is termed competence-induced cell lysis. This
activity, which involves production of the murein hydrolases
LytA, LytC, and CbpD, has been viewed as an autolytic mech-
anism for DNA release. However, Leiv Håvarstein (Norwegian
University of Life Sciences, Aas, Norway) reported new evi-
dence to suggest that the actual mechanism may involve tar-
geting of noncompetent cells by the competent fraction in a
population (i.e., fratricide rather than suicide). Håvarstein and
colleagues revisited a report that described an unusual cell
aggregation phenotype in competent pneumococci, but not in
parallel cultures of noncompetent cells (68). They found that
this phenotype is a consequence of DNA release and that it is
eliminated in a cbpD mutant or in a lytA-lytC double mutant.
They also discovered a CSP-induced immunity protein,
ComM, which somehow guards competent cells against the
actions of their own lysins. This system is postulated to provide
competent pneumococci with specialized weaponry to acquire
transforming DNA and nutrients while destroying noncompe-
tent competitor cells in the immediate environment (30).
VACCINES AND ANTIMICROBIALS
The prominent role of L. lactis in industrialized food fer-
mentations has fueled worldwide interest in the molecular
biology of this species for decades. The knowledge base assem-
bled from that work has provided greater control over indus-
trial processes that utilize this microbe and has also stimulated
interest in more novel applications. One of the most exciting
and promising new applications involves the use of lactococci
and nonpathogenic streptococci as live vectors for the delivery
of vaccines or therapeutic proteins to mucosal surfaces (71).
Historically, attenuated variants of pathogenic bacteria at-
tracted the greatest interest for vaccine development, but non-
pathogenic species offer an additional level of safety, and some
possess innate adjuvant activity (50). Gianni Pozzi (University
of Siena, Siena, Italy) outlined the advantages of mucosal tar-
geting with live vaccines and reported on experiments with S.
gordonii, a human commensal bacterium, as a host for surface
display of a candidacidal single-chain antibody. Pozzi found
that the recombinant strain was as effective as the best anti-
fungal drug (fuconazole) in clearing Candida infection in a rat
vaginal model, and the work indicated that live agents also
provided greater duration of control activity than traditional
topical medicines.
The efficacy of lactococci as live vaccines was reinforced in a
presentation by Immaculada Margarit (Chiron Vaccines, Si-
ena, Italy), who described work with lactococci engineered to
express pilin-like products from S. agalactiae (GBS). Pili are
proteinaceous filaments that facilitate host colonization by vir-
tue of their adhesive function. Once thought to be largely
confined to gram-negative species, pilin-like structures and
genes encoding their production have recently been described
in gram-positive pathogens, including GBS and S. pyogenes
(GAS) (39, 46). These structures have exciting potential as
candidates for new vaccines, because they are recognized by
serotype-specific antibodies, and mouse model studies have
shown that vaccines comprised of recombinant pilus proteins
confer protection against mucosal infection with GAS or GBS
(46, 58). These results are very promising, but concerns exist
that the effectiveness of protein vaccines may ultimately be
limited by the broad variation in pilus composition that exists
among strains. Margarit and coworkers showed that L. lactis
can be engineered to produce hybrid pili with protective anti-
gens from two different GBS and that the recombinant lacto-
cocci conferred protection against GBS lethal challenge on
either systemic or mucosal immunization (12). Further exploi-
tation of this system will determine whether lactococci can
function as a multivalent live vaccine against a broad range of
streptococcal diseases.
Lactococcal drug delivery systems can also be utilized in
therapies that do not involve specific microbial pathogens or
disease. Lothar Steidler (Alimentary Pharmabiotic Centre,
Cork, Ireland) delivered an update on his work to combat
human inflammatory bowel disease using L. lactis strains en-
gineered to express interleukin 10 (IL-10) and other biologi-
cally active proteins. Lactococci are able to synthesize and
process fully active IL-10, and previous work in a mouse colitis
model showed that these cells prevented the onset of new
disease and improved the histological condition of tissue in
mice with existing colitis (63). The lactococcal IL-10 construct
(LLIL-10) has now been tested in phase I human clinical trials
with 10 individuals suffering from Crohn’s disease. The pa-
tients showed no adverse reactions to the bacterium, and
clinical efficacy was indicated by a reduction in the levels of
C-reactive protein (10). Steidler also presented promising
information on potential treatment of food allergens
through LLIL-10 administration. The incidence of food al-
lergies is rising in Western countries, and concern over
contamination with common allergens is a leading cause of
food recalls in the United States. Interestingly, administra-
tion of LLIL-10 was found to reduce the severity of anaphy-
laxis in mice made allergic to the milk protein -lactoglobulin,
offering hope for future treatment of this condition in humans.
The vision of utilizing nonpathogenic lactococci, strepto-
1216 MEETING REVIEW J. BACTERIOL.
 o
n
 April 21, 2016 by UTAH STATE UNIV
http://jb.asm.org/
D
ow
nloaded from
 
cocci, or enterococci as hosts for live vaccines and drug deliv-
ery systems is almost certainly rooted in the historic recogni-
tion that these organisms produce a variety of compounds that
inhibit pathogenic bacteria. Some of the most potent antimi-
crobial agents produced by these cells are bacteriocins, pro-
teinaceous compounds that may exhibit very broad spectra of
inhibition. The significance of bacteriocins in food preserva-
tion continues to spur international inquiries into their nature,
genetics, and modes of action (49). Ingolf Nes (Norwegian
University of Life Sciences, Aas, Norway) described the activ-
ity and genetics of bacteriocins produced by enterococci, which
are collectively termed enterocins. Bacteriocin production is
particularly abundant among enterococci, and while most are
class II agents, class I and class III enterocins have also been
recognized. The prevalence of enterocin production may be
linked to the finding that genes for many of these antimicro-
bials are carried on plasmids and frequently lie in close prox-
imity to transposons or transposon-like elements. Interestingly,
many enterococci produce cocktails (two to at least four) of
different bacteriocins. In fact, 77% of 35 enterococcal strains
recovered from the feces of breast-fed infants produced more
that one bacteriocin. Though the biological significance of this
observation is still undefined, its prevalence and diversity sug-
gest that bacteriocins have an important role in cellular phys-
iology.
THE EIGHTH STREPTOCOCCAL GENETICS MEETING
As is evident from this brief overview of the meeting high-
lights, the future of streptococcal genetics holds tremendous
promise. Not captured in this article are the nearly 250 poster
presentations we were able to enjoy at the meeting. These
posters displayed the dedication and insight of a group of
talented young investigators vigorously attacking the gaps in
our present knowledge of streptococcal genetics, biochemistry,
physiology, and pathogenesis, and a number of these presen-
tations have been published in this issue of the Journal of
Bacteriology. Clearly, the field is growing and thriving. We
impatiently await the Eighth International Conference on the
Genetics of Streptococci, Lactococci, and Enterococci, which is
tentatively slated for 2009.
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AUTHOR’S CORRECTION
The Seventh International Conference on the Genetics of Streptococci,
Lactococci, and Enterococci
Robert A. Burne, Debra E. Bessen, Jeffery R. Broadbent, and Jean-Pierre Claverys
Department of Oral Biology, University of Florida, Gainesville, Florida; Department of Microbiology and Immunology,
New York Medical College, Valhalla, New York 10595; Western Dairy Center and Department of Nutrition and
Food Sciences, Utah State University, Logan, Utah; and Laboratoire de Microbiologie et Ge´ne´tique Mole´culaires,
UMR 5100 CNRS-Universite´ Paul Sabatier, 118 route de Narbonne, 31062 Toulouse Cedex 9, France
Volume 189, no. 4, p. 1209–1218, 2007. Page 1210, column 2, first complete paragraph, the last three sentences should be
replaced with the following: “Newly appearing type 19A strains account for most of the increased antibiotic resistance now seen
within the serotype. Work performed by Beall’s collaborator, Angela Brueggemann, depicted how a new invasive type 19A variant
appears to have arisen following horizontal transfer of a 39-kb DNA fragment containing serotype 19A capsule and flanking
penicillin-binding protein genes from an ST199 donor strain to a serotype 4 ST695 recipient strain. Serotype 4 capsular polysac-
charide corresponds to one of the seven vaccine serotypes successfully targeted by PCV7. This single genetic replacement event
appears to account for the rapid emergence of this vaccine escape 19A variant on the ST695 background.”
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